As of 2024-12-14, the Relative Valuation of Adverum Biotechnologies Inc (ADVM) is (82.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.72 USD, the upside of Adverum Biotechnologies Inc based on Relative Valuation is -1535.7%.
The range of the Relative Valuation is (51.22) - (86.51) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.5x - 24.4x | 17.5x |
| Forward P/E multiples | 11.3x - 19.1x | 18.8x |
| Fair Price | (51.22) - (86.51) | (82.12) |
| Upside | -995.4% - -1612.4% | -1535.7% |
| Date | P/E |
| 2024-11-29 | -1.47 |
| 2024-11-27 | -1.43 |
| 2024-11-26 | -1.36 |
| 2024-11-25 | -1.36 |
| 2024-11-22 | -1.33 |
| 2024-11-21 | -1.27 |
| 2024-11-20 | -1.36 |
| 2024-11-19 | -1.38 |
| 2024-11-18 | -1.51 |
| 2024-11-15 | -1.52 |
| 2024-11-14 | -1.60 |
| 2024-11-13 | -1.67 |
| 2024-11-12 | -1.74 |
| 2024-11-11 | -1.72 |
| 2024-11-08 | -1.77 |
| 2024-11-07 | -1.75 |
| 2024-11-06 | -1.75 |
| 2024-11-05 | -1.71 |
| 2024-11-04 | -1.67 |
| 2024-11-01 | -1.64 |
| 2024-10-31 | -1.61 |
| 2024-10-30 | -1.74 |
| 2024-10-29 | -1.72 |
| 2024-10-28 | -1.75 |
| 2024-10-25 | -1.76 |
| 2024-10-24 | -1.79 |
| 2024-10-23 | -1.79 |
| 2024-10-22 | -1.80 |
| 2024-10-21 | -1.83 |
| 2024-10-18 | -1.87 |
| 2024-10-17 | -1.79 |
| 2024-10-16 | -1.81 |
| 2024-10-15 | -1.70 |
| 2024-10-14 | -1.71 |
| 2024-10-11 | -1.69 |
| 2024-10-10 | -1.64 |
| 2024-10-09 | -1.66 |
| 2024-10-08 | -1.68 |
| 2024-10-07 | -1.64 |
| 2024-10-04 | -1.66 |
| 2024-10-03 | -1.61 |
| 2024-10-02 | -1.51 |
| 2024-10-01 | -1.46 |
| 2024-09-30 | -1.55 |
| 2024-09-27 | -1.53 |
| 2024-09-26 | -1.46 |
| 2024-09-25 | -1.46 |
| 2024-09-24 | -1.53 |
| 2024-09-23 | -1.52 |
| 2024-09-20 | -1.66 |